Chimeric antigen receptor T ( <scp>CAR‐T</scp> ) cells: Novel cell therapy for hematological malignancies-Reference-Cited by-同舟云学术

Chimeric antigen receptor T ( CAR‐T ) cells: Novel cell therapy for hematological malignancies

Published:2022-12-30 Issue:7 Volume:12 Page:7844-7858
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Abbasi Samane¹,Totmaj Milad Asghari²,Abbasi Masoumeh³,Hajazimian Saba⁴,Goleij Pouya⁵,Behroozi Javad⁶,Shademan Behrouz⁷,Isazadeh Alireza⁴^ORCID,Baradaran Behzad⁴^ORCID

Affiliation:

1. Department of Biology, Faculty of Sciences University of Guilan Rasht Iran

2. Department of Clinical Immunology, Faculty of Medicine The University of Manchester Manchester UK

3. Department of Microbiology, Malekan Branch Islamic Azad University Malekan Iran

4. Immunology Research Center Tabriz University of Medical Sciences Tabriz Iran

5. Department of Genetics, Faculty of Biology Sana Institute of Higher Education Sari Iran

6. Department of Genetics and Biotechnology, School of Medicine AJA University of Medical Sciences Tehran Iran

7. Department of Medical Biology, Faculty of Medicine Ege University Izmir Turkey

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5551

Reference129 articles.

1. Association of the blood eosinophil count with hematological malignancies and mortality

2. Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies—A prospective study

3. Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment

4. Regulatory role of microRNAs in cancer through Hippo signaling pathway

5. Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates for newly diagnosed and recurrent glioblastoma: a review of recent clinical trials;Current Opinion in Neurology;2024-09-13

2. NK/DC crosstalk-modulating antitumor activity via Sema3E/PlexinD1 axis for enhanced cancer immunotherapy;Immunologic Research;2024-09-05

3. Macrophage-based cancer immunotherapy: Challenges and opportunities;Experimental Cell Research;2024-09

4. Potential applications of macrophages in cancer immunotherapy;Biomedicine & Pharmacotherapy;2024-09

5. Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis;Cell;2024-09